Increased risk of stroke in patients with the A12308G polymorphism in mitochondria

Lancet (London, England)
|January 6, 2001
PubMed

Insights

A specific gene variant, A12308G, in the mitochondrial tRNA(Leu(CUN)) gene significantly increases stroke risk for individuals with the A3243G mutation causing MELAS syndrome. This finding aids in understanding MELAS stroke risk factors.

Area of Science:

  • Genetics
  • Neurology
  • Mitochondrial Diseases

Background:

  • The A3243G mutation in mitochondrial DNA is linked to MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke) syndrome.
  • The precise factors elevating stroke risk in MELAS patients remain incompletely understood.
  • Previous research indicated that mutations in the mitochondrial tRNA(Leu(CUN)) gene could modify the biochemical effects of the A3243G mutation in lung cancer cells.

Discussion:

  • This study investigated the tRNA(Leu(CUN)) gene in 48 unrelated patients carrying the A3243G mutation.
  • A specific polymorphism, A12308G, within the tRNA(Leu(CUN)) gene was identified.
  • The presence of the A12308G polymorphism was associated with a 2.17-fold increased risk of stroke in A3243G mutation carriers.

Key Insights:

  • The A12308G polymorphism in the mitochondrial tRNA(Leu(CUN)) gene is a significant risk factor for stroke in patients with the A3243G MELAS mutation.
  • This discovery provides a novel genetic marker for predicting stroke susceptibility in this patient population.
  • Understanding these genetic interactions is crucial for managing MELAS syndrome.

Outlook:

  • The findings have potential implications for genetic counseling and risk stratification in MELAS patients.
  • Further research could explore the mechanistic link between the A12308G polymorphism and stroke pathogenesis.
  • Identifying genetic modifiers like A12308G may lead to targeted therapeutic strategies for preventing stroke in mitochondrial diseases.

Related Concept Videos

Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...